Group 1: Company Development and Strategy - The company adheres to the principle of "Health Protection, Care for Life," aiming to provide reliable medical health products and comprehensive solutions for all age groups and consumer demographics [1] - The company focuses on innovation in research and development, striving for breakthroughs in new products and technologies, as well as upgrading existing product technologies [1] - Plans to enhance production management and establish a lean production system with stable production capacity, controllable costs, and high-quality service [1] Group 2: Hearing Aid Business Expansion - The company has established over 500 hearing fitting centers across provinces such as Hunan, Guangxi, Sichuan, Shaanxi, Shandong, Hainan, and Guangdong [2] - Future plans include expanding into 1-2 new provinces and increasing market share in existing cities through a combination of expansion and acquisitions [2] - The company aims to position its hearing aid business as a leading chain enterprise in terms of scale and service capability in China [2] Group 3: Production Facilities and Product Lines - The new production bases in Changsha and Xiangyin have completed their first-phase projects and are now operational [2] - The Changsha base primarily produces health monitoring and respiratory support products, including blood pressure monitors, thermometers, nebulizers, oxygen machines, and IVD products [2] - The Xiangyin base focuses on rehabilitation aids and medical care products, such as nursing beds, transfer machines, wheelchairs, masks, and medical dressings [2] Group 4: Financial and Dividend Information - The company disclosed its 2022 profit distribution plan on April 26, with distribution expected to be completed within two months after approval at the annual shareholders' meeting [2]
可孚医疗(301087) - 2023年5月11日投资者关系活动记录表